Inotiv, inc. announces pricing of public offering of 2,647,059 common shares

West lafayette, ind., april 21, 2021 (globe newswire) -- inotiv, inc. (nasdaq:notv) (the “company”, “we”, “our” or “inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services, today announced the pricing of an underwritten public offering of 2,647,059 of its common shares at a price to the public of $17.00 per share. the gross proceeds to the company from this offering, before deducting the underwriting discount and offering expenses payable by the company, are expected to be approximately $45.0 million. all of the shares are being offered by the company. the offering is expected to close on or about april 23, 2021. in addition, the company has granted the underwriter a 30-day option to purchase up to an additional 397,058 of its common shares at the public offering price, less the underwriting discount.
NOTV Ratings Summary
NOTV Quant Ranking